Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations
- PMID: 10750558
- DOI: 10.1359/jbmr.2000.15.3.442
Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations
Erratum in
- J Bone Miner Res 2000 Aug;15(8):1641
Abstract
The EXT genes are a group of putative tumor suppressor genes that previously have been shown to participate in the development of hereditary multiple exostoses (HME), HME-associated and isolated chondrosarcomas. Two HME disease genes, EXT1 and EXT2, have been identified and are expressed ubiquitously. However, the only known effect of mutations in the EXT genes is on chondrocyte function as evidenced by aberrant proliferation of chondrocytes leading to formation of bony, cartilage-capped projections (exostoses). In this study, we have characterized exostosis chondrocytes from three patients with HME (one with EXT1 and two with EXT2 germline mutations) and from one individual with a non-HME, isolated exostosis. At the light microscopic level, exostosis chondrocytes have a stellate appearance with elongated inclusions in the cytoplasm. Confocal and immunofluorescence of in vitro and in vivo chondrocytes showed that these massive accumulations are composed of actin bundled by 1.5-microm repeat cross-bridges of alpha-actinin. Western blot analysis shows that exostosis chondrocytes from two out of three patients aberrantly produce high levels of muscle-specific alpha-actin, whereas beta-actin levels are similar to normal chondrocytes. These findings suggest that mutations in the EXT genes cause abnormal processing of cytoskeleton proteins in chondrocytes.
Similar articles
-
Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.Cell Motil Cytoskeleton. 2001 Feb;48(2):149-62. doi: 10.1002/1097-0169(200102)48:2<149::AID-CM1005>3.0.CO;2-3. Cell Motil Cytoskeleton. 2001. PMID: 11169766
-
EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.Dev Dyn. 2000 Jul;218(3):452-64. doi: 10.1002/1097-0177(200007)218:3<452::AID-DVDY1000>3.0.CO;2-P. Dev Dyn. 2000. PMID: 10878610
-
Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.Differentiation. 2005 Jun;73(5):212-21. doi: 10.1111/j.1432-0436.2005.00025.x. Differentiation. 2005. PMID: 16026543
-
Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.Hum Mutat. 2000;15(3):220-7. doi: 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K. Hum Mutat. 2000. PMID: 10679937 Review.
-
[From gene to disease; hereditary multiple exostoses].Ned Tijdschr Geneeskd. 2002 Jan 26;146(4):162-4. Ned Tijdschr Geneeskd. 2002. PMID: 11845565 Review. Dutch.
Cited by
-
Perlecan: an important component of the cartilage pericellular matrix.J Musculoskelet Neuronal Interact. 2002 Dec;2(6):511-6. J Musculoskelet Neuronal Interact. 2002. PMID: 15758379 Free PMC article.
-
Advanced colon cancer coexisting with multiple Osteochondromatosis in a child; coincidence or causality? - A case report.Int J Surg Case Rep. 2023 Jul;108:108427. doi: 10.1016/j.ijscr.2023.108427. Epub 2023 Jun 21. Int J Surg Case Rep. 2023. PMID: 37354823 Free PMC article.
-
Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro.Connect Tissue Res. 2003;44 Suppl 1(Suppl 1):196-201. Connect Tissue Res. 2003. PMID: 12952197 Free PMC article.
-
The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.J Clin Invest. 2001 Aug;108(4):511-6. doi: 10.1172/JCI13737. J Clin Invest. 2001. PMID: 11518722 Free PMC article. Review. No abstract available.
-
Spatiotemporal distribution of heparan sulfate epitopes during murine cartilage growth plate development.Histochem Cell Biol. 2006 Dec;126(6):713-22. doi: 10.1007/s00418-006-0203-4. Epub 2006 Jul 12. Histochem Cell Biol. 2006. PMID: 16835755
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous